ATM and small cell lung carcinoma: In line with these findings and with previous reports18, ATM-deficient mESCs were substantially more sensitive than WT cells to the CPT derivative topotecan, which is used clinically to treat ovarian, cervical, and small-cell lung cancers (Fig. 1b, c).